PAS
TMO icon

Park Avenue Securities’s Thermo Fisher Scientific TMO Stock Holding History

Park Avenue Securities’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.99M Buy
11,955
+436
+4% +$209K 0.04% 344
2026
Q1 		$5.66M Buy
11,519
+138
+1% +$74.9K 0.04% 289
2025
Q4 		$6.59M Sell
11,381
-126
-1% -$71.3K 0.06% 252
2025
Q3 		$5.58M Sell
11,507
-419
-4% -$195K 0.04% 297
2025
Q2 		$4.84M Sell
11,926
-3,405
-22% -$1.42M 0.04% 279
2025
Q1 		$7.63M Sell
15,331
-1,542
-9% -$835K 0.09% 153
2024
Q4 		$8.78M Sell
16,873
-1,293
-7% -$711K 0.09% 155
2024
Q3 		$11.2M Sell
18,166
-1,063
-6% -$629K 0.13% 114
2024
Q2 		$10.6M Buy
19,229
+13
+0.1% +$7.45K 0.13% 117
2024
Q1 		$11.2M Buy
19,216
+1,791
+10% +$1M 0.14% 105
2023
Q4 		$9.25M Sell
17,425
-80
-0.5% -$38.7K 0.13% 106
2023
Q3 		$8.86M Sell
17,505
-976
-5% -$520K 0.14% 103
2023
Q2 		$9.64M Buy
18,481
+344
+2% +$186K 0.15% 94
2023
Q1 		$10.5M Sell
18,137
-735
-4% -$414K 0.18% 79
2022
Q4 		$10.4M Buy
18,872
+114
+0.6% +$60.4K 0.18% 81
2022
Q3 		$9.51M Buy
18,758
+1,298
+7% +$726K 0.19% 71
2022
Q2 		$9.48M Buy
17,460
+873
+5% +$481K 0.18% 66
2022
Q1 		$9.8M Buy
16,587
+645
+4% +$371K 0.17% 68
2021
Q4 		$10.6M Buy
15,942
+797
+5% +$498K 0.19% 65
2021
Q3 		$8.65M Buy
15,145
+718
+5% +$394K 0.17% 64
2021
Q2 		$7.28M Buy
14,427
+755
+6% +$356K 0.15% 66
2021
Q1 		$6.24M Buy
13,672
+1,410
+11% +$673K 0.15% 61
2020
Q4 		$5.71M Sell
12,262
-1,261
-9% -$591K 0.16% 56
2020
Q3 		$5.97M Buy
13,523
+1,065
+9% +$440K 0.2% 53
2020
Q2 		$4.51M Buy
+12,458
New +$4.18M 0.17% 55
2020
Q1 		– Sell
-9,715
Closed -$3.16M – 575
2019
Q4 		$3.16M Buy
9,715
+289
+3% +$87.6K 0.13% 67
2019
Q3 		$2.75M Buy
+9,426
New +$2.7M 0.13% 62
2019
Q2 		– Sell
-7,562
Closed -$2.09M – 452
2019
Q1 		$2.09M Buy
+7,562
New +$1.88M 0.11% 68
2017
Q3 		– Sell
-2,709
Closed -$480K – 215
2017
Q2 		$480K Buy
+2,709
New +$455K 0.05% 83
2016
Q3 		– Sell
-1,904
Closed -$284K – 94
2016
Q2 		$284K Buy
+1,904
New +$281K 0.05% 61

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Park Avenue Securities's TMO Position: Q2 2026 in Review

Park Avenue Securities increased its Thermo Fisher Scientific (TMO) stake by 3.8% in Q2 2026, buying an estimated $209K and bringing the position to 11,955 shares worth $5.99M. The position accounts for 0.04% of the portfolio, ranked #344.

Park Avenue Securities first reported a position in TMO in Q2 2016 and has held it in 30 quarters since. The position peaked at $11.2M in Q3 2024. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Park Avenue Securities held 11,955 shares of Thermo Fisher Scientific worth $5.99M as of Q2 2026.
  • Park Avenue Securities bought 436 Thermo Fisher Scientific shares in Q2 2026, an estimated $209K.
  • Thermo Fisher Scientific made up 0.04% of Park Avenue Securities's portfolio in Q2 2026, its #344 holding.
  • Park Avenue Securities first reported a position in Thermo Fisher Scientific in Q2 2016 and has held it in 30 quarters since.
  • Park Avenue Securities's Thermo Fisher Scientific position peaked at $11.2M in Q3 2024.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.